Palatin Technologies
PTN
#10273
Rank
NZ$43.51 M
Marketcap
NZ$24.45
Share price
1.22%
Change (1 day)
16,268.55%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -NZ$8.39 Million

According to Palatin Technologies's latest financial reports the company's current earnings are NZ$8.84 Million. In 2024 the company made an earning of -NZ$46.56 Million, an increase over its 2023 earnings that were of -NZ$56.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$8.39 Million-81.98%
2024 -NZ$46.56 Million-16.9%
2023 -NZ$56.02 Million5.99%
2022 -NZ$52.86 Million-13.7%
2021 -NZ$61.25 Million33.25%
2020 -NZ$45.97 Million-172.11%
2019 NZ$63.73 M2352.33%
2018 NZ$2.59 M-94.13%
2017 NZ$44.28 M-154.92%
2016 -NZ$80.64 Million3.67%
2015 -NZ$77.79 Million878%
2014 -NZ$7.96 Million-72.64%
2013 -NZ$29.07 Million-33.11%
2012 -NZ$43.46 Million77.71%
2011 -NZ$24.46 Million
2003 -NZ$41.41 Million29.93%
2002 -NZ$31.87 Million36.18%
2001 -NZ$23.41 Million
1999 -NZ$19.43 Million6.04%
1998 -NZ$18.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.89 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.34 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$1.38 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$20.75 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.28 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$0.16 B-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-NZ$50.96 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$0.11 Billion 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA